Droxidopa Capsule
Product Images NDC 51407-765

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 51407-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-765-90.jpg (51407 765 90)

Each capsule contains 100 mg of droxidopa. The usual dosage and full prescribing information can be found in the package insert. The capsules should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F) under controlled room temperature conditions. They should be dispensed in a tight, light-resistant container with a child-resistant closure. Do not use if the printed seal under the cap is broken or missing. Keep out of reach of children. This product is manufactured by ScieGen Pharmaceuticals, Inc. and marketed by GSMS, Incorporated.*

FDA Label Image

51407-766-90.jpg (51407 766 90)

FDA Label Image

51407-767-90.jpg (51407 767 90)

FDA Label Image

Mean Change In Ohsa (Droxidopa Fig01)

Baseline Value: 5.1 Units in Both Groups: 0.5 Treatment: Droxidopa (25) Mean Change in Dizziness: 3.5 Duration: Baseline to Week 5 Treatment Phase: Double-Blind*

FDA Label Image

Distribution Of Patients By Change In Ohsa (Droxidopa Fig02)

FDA Label Image

Droxidopa-01 (Droxidopa Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.